Cite
HARVARD Citation
Hanafy, A. et al. (2016). Recombinant HBV vaccine enhances the rate of sustained virological response when early initiated after anti‐HCV combination therapy. Journal of medical virology. 88 (1), pp. 86-93. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hanafy, A. et al. (2016). Recombinant HBV vaccine enhances the rate of sustained virological response when early initiated after anti‐HCV combination therapy. Journal of medical virology. 88 (1), pp. 86-93. [Online].